The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Lisa Oliver sits on this spectrum.
This scientist: 110 publications — 8th percentile
8% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa Oliver sits on this spectrum.
This scientist: 52 D-Index — 16th percentile
16% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Lisa Oliver is affiliated with the University of Nantes in France, specializing in biochemistry, genetics, and molecular biology, with a marked focus on medicine. Their research spans multiple subfields including molecular biology, oncology, genetics, biomedical engineering, and cell biology.
The scientist's recent scholarly output includes publications that primarily address cancer biology and treatment resistance, with specific attention to glioma diagnosis and therapy. Notable papers include "Three-dimensional in vitro culture models in oncology research" published in 2022 in Cell & Bioscience, "Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress" from 2021 in Frontiers in Molecular Biosciences, and "Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma" published in 2020 in Cell Death and Disease. Other recent works include "Mitochondria transfer from tumor-activated stromal cells (TASC) to primary Glioblastoma cells" published in 2020 in Biochemical and Biophysical Research Communications and "Drug resistance in glioblastoma: are persisters the key to therapy?" from 2020 in Cancer Drug Resistance.
Lisa Oliver frequently collaborates with several researchers in their field. The regular co-authors include:
Their work is often published in recurring scientific venues, among which the most frequent are:
The research topics commonly addressed include:
Emine Er;Lisa Oliver;Pierre-François Cartron;Philippe Juin
E Jacquemin;L Jonet;L Oliver;K Bugra
Bellot G;Bellot G;Cartron Pf;Cartron Pf;Er E;Er E;Oliver L;Oliver L
Tristan Gallenne;Fabien Gautier;Fabien Gautier;Lisa Oliver;Lisa Oliver;Eric Hervouet;Eric Hervouet
Nadine Platet;Shi Yong Liu;Michèle El Atifi;Lisa Oliver
François M. Vallette;Christophe Olivier;Frédéric Lézot;Lisa Oliver
Pierre-François Cartron;Muriel Priault;Lisa Oliver;Khaled Meflah
Philippe Juin;Maude Pelletier;Lisa Oliver;Karine Tremblais
Lisa Oliver;Erika Hue;Muriel Priault;François M. Vallette
Pierre-Francois Cartron;Philippe Juin;Lisa Oliver;Stéphane A Martin
Sandra Frank;Lisa Oliver;Corinne Lebreton-De Coster;Carole Moreau
Christophe Olivier;Lisa Oliver;Lisenn Lalier;François M Vallette
Pierre-François Cartron;Hubert Arokium;Hubert Arokium;Lisa Oliver;Khaled Meflah
L. Oliver;C. Olivier;F. B. Marhuenda;M. Campone
Pierre-François Cartron;Lisa Oliver;Stéphane Martin;Carole Moreau
Morfouace M;Lalier L;Oliver L;Cheray M
Kristell Oizel;Cynthia Chauvin;Lisa Oliver;Catherine Gratas
Oliver Lj;Rifkin Db;Gabrilove J;Hannocks Mj
Lisa Oliver;François M. Vallette
Flore Renaud;Sophie Desset;Lisa Oliver;Guillermo Gimenez-Gallego
If you think any of the details on this page are incorrect, let us know.
University of Paris-Saclay
University of Toronto
University of Massachusetts Chan Medical School
National Oceanic and Atmospheric Administration
Tohoku University
University of Massachusetts Chan Medical School
State University of Campinas
University of Washington
University of Oxford
Seoul National University
Massey University
Institut de Ciència de Materials de Barcelona
Institute of Cancer Research
Utrecht University
Swinburne University of Technology
Umeå University
